한글목차

개요

레드 바이오테크놀러지 시장은 2023-2028년간 1,745억 6,000만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 6.23%를 나타낼 것으로 예측됩니다.

레드 바이오테크놀러지 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 게놈 연구의 발전, 만성질환 유병률 증가, 세계적인 고령화 진전 등에 의해 시장 성장이 촉진되고 있습니다.

본 조사에서는 향후 몇 년간 레드 바이오테크놀러지 시장 성장을 촉진하는 주요인 중 하나로서 줄기세포 연구와 치료 증가를 들고 있습니다. 바이오의약품이나 치료용 단백질 생산량 증가, 바이오인포매틱스나 데이터 분석의 보급은 시장의 높은 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 레드 바이오테크놀러지 시장(2018-2022년)
• 제품별 부문 분석(2018-2022년)
• 최종사용자별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 단클론항체 : 시장 규모와 예측(2023-2028년)
• 유전자 치료 : 시장 규모와 예측(2023-2028년)
• 다중클론항체 : 시장 규모와 예측(2023-2028년)
• 세포 기반 면역치료 제품 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 제품별

제7장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 제약회사 및 바이오테크놀러지 기업 : 시장 규모와 예측(2023-2028년)
• CMO 및 CRO : 시장 규모와 예측(2023-2028년)
• 학술연구기관 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 최종사용자별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Amgen Inc.
• Astellas Pharma Inc.
• AstraZeneca Plc
• Bayer AG
• Biogen Inc.
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Co.
• Bruker Corp.
• F. Hoffmann La Roche Ltd.
• Gilead Sciences Inc.
• Merck KGaA
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• STEMCELL Technologies Inc.
• Teva Pharmaceutical Industries Ltd.

제13장 부록

영문목차

Abstract

The red biotechnology market is forecasted to grow by USD 174.56 bn during 2023-2028, accelerating at a CAGR of 6.23% during the forecast period. The report on the red biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in genomic research, an increase in the prevalence of chronic diseases, and a growing aging population globally.

Technavio's red biotechnology market is segmented as below:

By Product

• Monoclonal antibodies
• Gene therapy
• Polyclonal antibodies
• Cell-based immunotherapy products
• Others

By End-user

• Pharmaceutical and biotechnology companies
• CMOs and CROs
• Academic research institutes

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising stem cell research and therapies as one of the prime reasons driving the red biotechnology market growth during the next few years. Also, the increasing production of biopharmaceuticals and therapeutic proteins and the rising prevalence of bioinformatics and data analytics will lead to sizable demand in the market.

The report on the red biotechnology market covers the following areas:

• Red biotechnology market sizing
• Red biotechnology market forecast
• Red biotechnology market industry analysis

The robust vendor analysis is designed to help clients improve their market position. In line with this, this report provides a detailed analysis of several leading red biotechnology market vendors that include Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Bruker Corp., CRISPR Therapeutics AG, Editas Medicine Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Mesoblast Ltd., Moderna Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., STEMCELL Technologies Inc., and Teva Pharmaceutical Industries Ltd.. Also, the red biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global red biotechnology market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global red biotechnology market 2018 - 2022 ($ billion)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Monoclonal antibodies - Market size and forecast 2023-2028
• Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
• 6.4 Gene therapy - Market size and forecast 2023-2028
• Exhibit 38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
• 6.5 Polyclonal antibodies - Market size and forecast 2023-2028
• Exhibit 42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
• 6.6 Cell-based immunotherapy products - Market size and forecast 2023-2028
• Exhibit 46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
• Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ billion)
• Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 56: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 57: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 58: Chart on Comparison by End-user
• Exhibit 59: Data Table on Comparison by End-user
• 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
• Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• 7.4 CMOs and CROs - Market size and forecast 2023-2028
• Exhibit 64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)
• 7.5 Academic research institutes - Market size and forecast 2023-2028
• Exhibit 68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
• Exhibit 71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by End-user
• Exhibit 72: Market opportunity by End-user ($ billion)
• Exhibit 73: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
• Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
• Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 Germany - Market size and forecast 2023-2028
• Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 117: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 119: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 121: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 122: Matrix on vendor position and classification
• 12.3 Amgen Inc.
• Exhibit 123: Amgen Inc. - Overview
• Exhibit 124: Amgen Inc. - Product / Service
• Exhibit 125: Amgen Inc. - Key offerings
• 12.4 Astellas Pharma Inc.
• Exhibit 126: Astellas Pharma Inc. - Overview
• Exhibit 127: Astellas Pharma Inc. - Product / Service
• Exhibit 128: Astellas Pharma Inc. - Key news
• Exhibit 129: Astellas Pharma Inc. - Key offerings
• 12.5 AstraZeneca Plc
• Exhibit 130: AstraZeneca Plc - Overview
• Exhibit 131: AstraZeneca Plc - Product / Service
• Exhibit 132: AstraZeneca Plc - Key news
• Exhibit 133: AstraZeneca Plc - Key offerings
• 12.6 Bayer AG
• Exhibit 134: Bayer AG - Overview
• Exhibit 135: Bayer AG - Business segments
• Exhibit 136: Bayer AG - Key news
• Exhibit 137: Bayer AG - Key offerings
• Exhibit 138: Bayer AG - Segment focus
• 12.7 Biogen Inc.
• Exhibit 139: Biogen Inc. - Overview
• Exhibit 140: Biogen Inc. - Product / Service
• Exhibit 141: Biogen Inc. - Key offerings
• 12.8 Boehringer Ingelheim International GmbH
• Exhibit 142: Boehringer Ingelheim International GmbH - Overview
• Exhibit 143: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 144: Boehringer Ingelheim International GmbH - Key news
• Exhibit 145: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 146: Boehringer Ingelheim International GmbH - Segment focus
• 12.9 Bristol Myers Squibb Co.
• Exhibit 147: Bristol Myers Squibb Co. - Overview
• Exhibit 148: Bristol Myers Squibb Co. - Product / Service
• Exhibit 149: Bristol Myers Squibb Co. - Key news
• Exhibit 150: Bristol Myers Squibb Co. - Key offerings
• 12.10 Bruker Corp.
• Exhibit 151: Bruker Corp. - Overview
• Exhibit 152: Bruker Corp. - Business segments
• Exhibit 153: Bruker Corp. - Key news
• Exhibit 154: Bruker Corp. - Key offerings
• Exhibit 155: Bruker Corp. - Segment focus
• 12.11 F. Hoffmann La Roche Ltd.
• Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
• 12.12 Gilead Sciences Inc.
• Exhibit 161: Gilead Sciences Inc. - Overview
• Exhibit 162: Gilead Sciences Inc. - Product / Service
• Exhibit 163: Gilead Sciences Inc. - Key news
• Exhibit 164: Gilead Sciences Inc. - Key offerings
• 12.13 Merck KGaA
• Exhibit 165: Merck KGaA - Overview
• Exhibit 166: Merck KGaA - Business segments
• Exhibit 167: Merck KGaA - Key news
• Exhibit 168: Merck KGaA - Key offerings
• Exhibit 169: Merck KGaA - Segment focus
• 12.14 Pfizer Inc.
• Exhibit 170: Pfizer Inc. - Overview
• Exhibit 171: Pfizer Inc. - Product / Service
• Exhibit 172: Pfizer Inc. - Key news
• Exhibit 173: Pfizer Inc. - Key offerings
• 12.15 Regeneron Pharmaceuticals Inc.
• Exhibit 174: Regeneron Pharmaceuticals Inc. - Overview
• Exhibit 175: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibit 176: Regeneron Pharmaceuticals Inc. - Key offerings
• 12.16 STEMCELL Technologies Inc.
• Exhibit 177: STEMCELL Technologies Inc. - Overview
• Exhibit 178: STEMCELL Technologies Inc. - Product / Service
• Exhibit 179: STEMCELL Technologies Inc. - Key offerings
• 12.17 Teva Pharmaceutical Industries Ltd.
• Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 185: Inclusions checklist
• Exhibit 186: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 187: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 188: Research methodology
• Exhibit 189: Validation techniques employed for market sizing
• Exhibit 190: Information sources
• 13.5 List of abbreviations
• Exhibit 191: List of abbreviations